Pharmafile Logo
Pharmafocus logo
Advanced Search

VBP

Showing 14 posts of 44 posts found.

ABPI image

ABPI outlines vision for drug pricing reform

August 3, 2012
Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …

News
ABPI image

New UK drug pricing system will ‘stifle innovation’

August 2, 2012
Sales and Marketing ABPI, PPRS, UK government, VBP

The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …

News
abpi image

Sluggish growth forecast concerns ABPI

July 3, 2012
Sales and Marketing ABPI, NHS, OHE, VBP, government

New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …

News
ABPI image

ABPI to no longer ‘shy away’ from big issues

June 27, 2012
Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead

The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …

News

The European Medicines Group: focused on UK market access

June 25, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access

Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …

Feature
Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Feature
ABPI image

ABPI ‘fears for future of UK research’ ahead of pricing talks

June 7, 2012
Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …

News
Andrew Lansley

NICE to be sidelined on cost effectiveness – once again

May 17, 2012
Sales and Marketing NICE, VBP

Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …

News
catherine_meaden

ABPI appoints Catherine Meaden as head of policy and public affairs

March 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS Direct, VBP

The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …

Appointment

UK pharma downbeat on its future – survey

November 8, 2011
Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …

News

NHS Confederation: value-based pricing could increase NHS costs

March 18, 2011
Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing

Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …

News
Association of the British Pharmaceutical Industry

Pharma industry wary of UK drug pricing changes

March 17, 2011
Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing

The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …

News

UK pharma faces rising costs from value-based pricing

December 3, 2010
Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing

The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …

News

NICE: the end of an era

August 9, 2010
Sales and Marketing Andrew Lansley, NICE, VBP, government

NICE is undergoing a momentus shift in its role which will see it leave behind the frequent clashes and controversy …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026